PremierMD Spravato Treatment Centers

PremierMD in Hoboken, New Jersey offers Spravato (esketamine) for adults with treatment-resistant depression, part of one of New Jersey's most experienced Spravato networks with over 20,000 treatments administered. The same skilled providers rotate across all locations for consistent care.

Spravato is an FDA-approved nasal spray that works through different neural pathways than traditional antidepressants, helping rebuild connections affected by depression and often delivering improvement within hours or days for patients who have not responded to other medications.

Located steps from the PATH station and easily accessible for NYC commuters without a car, the Hoboken center provides Spravato treatment along with psychiatric medication management and therapeutic counseling in a comfortable setting. Most insurance plans are accepted, including Medicare and Medicaid.